Treatment Options for Scalp Psoriasis
Topical corticosteroids are the first-line treatment for scalp psoriasis, with class 1 (ultra-high potency) formulations like clobetasol propionate being most effective for initial therapy of thick, chronic plaques. 1
First-Line Therapy: Topical Corticosteroids
Potency Selection
Ultra-high potency (Class 1): For thick, chronic plaques
- Clobetasol propionate 0.05% foam or solution - achieves 50% or better clearing in 81% of patients after 2 weeks 1
- Recommended for initial treatment of moderate to severe cases
High potency (Class 2-3):
- Fluticasone propionate 0.005% ointment - 68-69% of patients achieve good to excellent results after 4 weeks 2
Medium potency (Class 4):
Lower potency (Class 5-7):
- Consider for maintenance, sensitive areas, or mild disease
Formulation Selection
- Solutions, foams, and shampoos are preferred for scalp application due to ease of use and cosmetic acceptability 3
- Clobetasol propionate shampoo 0.05% is particularly effective and convenient for scalp application 4, 5
Treatment Regimen
- Apply once or twice daily for initial treatment 1
- Twice daily application of clobetasol propionate solution shows superior efficacy compared to once daily application (100% vs 65% good/excellent response) 6
- Continue for 2-4 weeks for initial treatment 1
- Limit continuous use of class 1 corticosteroids to 2-4 weeks to reduce risk of side effects 2, 1
Maintenance Therapy
- After clinical improvement, gradually reduce frequency of application 2, 1
- For long-term control, twice weekly application of clobetasol propionate shampoo can maintain remission:
- 31.1% of patients remain relapse-free after 6 months with twice weekly maintenance 5
- Consider alternating with other agents to minimize steroid exposure
Alternative and Adjunctive Treatments
Vitamin D analogues:
- Calcipotriene foam or calcipotriene plus betamethasone dipropionate gel for 4-12 weeks 1
- Can be used in combination with corticosteroids for enhanced efficacy
Intralesional corticosteroids:
- For thick, non-responding lesions
- Triamcinolone acetonide (up to 20 mg/mL) every 3-4 weeks 1
For moderate-to-severe psoriasis with inadequate response to topicals:
- Systemic agents like apremilast, adalimumab, or etanercept should be considered 3
Safety Considerations and Monitoring
Local adverse effects of topical corticosteroids include:
- Skin atrophy, striae, folliculitis, telangiectasia, and purpura 1
- More common at steroid-sensitive sites and with prolonged use
Systemic absorption:
Tachyphylaxis (decreased effectiveness with continued use) may occur with long-term use 2
Rebound can occur with abrupt withdrawal; implement gradual tapering 1
Clinical Pearls
- Scalp involvement occurs in up to 80% of individuals with psoriasis and significantly impacts quality of life 3
- Medicated shampoos provide a more convenient alternative than creams or ointments for scalp application 4
- For frequent relapsers, twice weekly maintenance therapy can significantly delay time to relapse 5
- Long-term use (>12 weeks) should only be done under careful physician supervision 1
- Consider combination therapy for enhanced efficacy - corticosteroid shampoo alternating with antifungal shampoo has shown efficacy in seborrheic dermatitis and may be beneficial in some cases of scalp psoriasis 8